Mga Batayang Estadistika
| LEI | 549300I4GMO6D34U1T02 |
| CIK | 707549 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Lam Research Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 11, 2025 |
Exhibit 19.1 Document Name: LGL-70983 Insider Trading [LGL-1001] Policy Revision: 14.0 Page 1 of 17 Authorized By Title: SVP, Chief Legal Officer 1.0Statement of Policy Except as expressly permitted by this Insider Trading Policy (inclusive of Appendix A, referred to herein as the “Policy”), Lam Research Corporation prohibits any transaction in its securities by a person possessing material non-pu |
|
| August 11, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 29, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 11, 2025 |
Exhibit 4.6 DESCRIPTION OF COMMON STOCK The following summary description sets forth some of the general terms and provisions of our common stock. Because this is a summary description, it does not contain all of the information that may be important to you. For a more detailed description of the common stock, you should refer to the provisions of our Restated Certificate of Incorporation, as amen |
|
| August 11, 2025 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 11, 2025) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Lam Research Salzburg GmbH Austria Lam Research Belgium BV Belgium Novellus Systems, Inc. |
|
| August 11, 2025 |
Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) || THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its charter) (J |
|
| August 11, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3ASR (Form Type) Lam Research Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common Stock, par value $0. |
|
| August 11, 2025 |
As filed with the Securities and Exchange Commission on August 11, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 11, 2025 Registration No. |
|
| July 30, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 29, 2025 FREMONT, Calif., July 30, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 29, 2025 (the “June 2025 quarter”). Highlights for the June 2025 quarter were as follows: •Revenue of $5.17 billion. •U. |
|
| July 30, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2025 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| June 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 A. Full tit |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| June 2, 2025 |
Conflict Minerals Report of Lam Research Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2024, through December 31, 2024 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, for |
|
| May 21, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 20, 2025 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporatio |
|
| May 21, 2025 |
Amended and Restated Bylaws of of Lam Research Corporation Dated May 20, 2025 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF LAM RESEARCH CORPORATION Amended and restated as of May 20, 2025 ARTICLE I CORPORATE OFFICES 1.1REGISTERED OFFICE The registered office of the corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. The name of the registered agent of the corporation at such location is The Corporation Trust Company. 1.2OTHER OFFICES The b |
|
| April 25, 2025 |
Exhibit 10.3 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to [Print Name] (the “Participant”) on the ter |
|
| April 25, 2025 |
Form of Restricted Stock Unit Award Agreement (U.S. Participants) - 2015 Stock Incentive Plan Exhibit 10.1 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”), Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to [Print Name] (the “Participant”) on the terms and conditions as set forth in this Restricted S |
|
| April 25, 2025 |
Exhibit 10.4 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to [Print Name] (the “Participant”) o |
|
| April 25, 2025 |
Exhibit 10.2 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”), Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to [Print Name] (the “Participant”) on the terms and conditions as set forth in this Res |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEARCH |
|
| April 23, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 30, 2025 FREMONT, Calif., April 23, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 30, 2025 (the “March 2025 quarter”). Highlights for the March 2025 quarter were as follows: •Revenue of $4.72 billion |
|
| April 23, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2025 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| January 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEA |
|
| January 29, 2025 |
EXHIBIT 10.1 EXECUTION VERSION THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of January 27, 2025 among LAM RESEARCH CORPORATION the Lenders Party Hereto JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., BARCLAYS BANK PLC, BNP PARIBAS, CITIBANK, N.A., and MIZUHO BANK, LTD., as Syndication Agents and DEUTSCHE BANK SECURITIES INC, GOLDMAN SACHS BANK USA, MUFG BANK, LTD. |
|
| January 29, 2025 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 29, 2024 FREMONT, Calif., January 29, 2025 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 29, 2024 (the “December 2024 quarter”). Highlights for the December 2024 quarter were as follows: •Revenue of |
|
| January 29, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2025 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| January 29, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 29, 2025 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| November 7, 2024 |
Submission of Matters to a Vote of Security Holders Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 5, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESE |
|
| October 23, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 23, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 23, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended September 29, 2024 FREMONT, Calif., October 23, 2024 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 29, 2024 (the “September 2024 quarter”). On May 21, 2024, the Company announced a ten-for-one stock split w |
|
| October 2, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| October 2, 2024 |
Certificate of Amendment to Restated Certificate of Incorporation of Lam Research Corporation Exhibit 3.1 CERTIFICATE OF AMENDMENT TO RESTATED CERTIFICATE OF INCORPORATION OF LAM RESEARCH CORPORATION Lam Research Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify that: FIRST: That the first paragraph of Article FOURTH of the Restated Certificate of Incorporation is hereby ame |
|
| September 25, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Con |
|
| September 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use |
|
| September 25, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 25, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| September 18, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| August 30, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 28, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| August 30, 2024 |
Lam Research Appoints Ita Brennan and Mark Fields to Board of Directors Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Appoints Ita Brennan and Mark Fields to Board of Directors FREMONT, Calif., August 30, 2024 – Lam Research Corp. (Nasdaq: LRCX) today announced that Ita Brennan and Mark Fields have joined its board of directors, effective August 30, 2024. Brennan brings to the board significant senior executive-level financial management expertise in the technology |
|
| August 29, 2024 |
Executive Change in Control Policy, as amended and restated. Exhibit 10.27 Executive Change in Control Policy EXECUTIVE CHANGE IN CONTROL POLICY Amended and Restated Effective May 15, 2024 This Executive Change in Control Policy (this “Policy”) is adopted by the Board of Directors (the “Board”) of Lam Research Corporation, a Delaware corporation (the “Company”) and is amended and restated with an effective date of May 15, 2024. It is intended to comply with |
|
| August 29, 2024 |
Non-employee Director Compensation Program, as amended. Exhibit 10.38 Lam Research Corporation Non-Employee Director Compensation Program Amended effective as of May 15, 2024 Objective To target and pay the non-employee members of the board of directors (the “Board”) of Lam Research Corporation (the “Company”) at the median of the Company’s peer group, as measured every other year. Annual Cash Retainers For service as a director beginning with calendar |
|
| August 29, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 29, 2024 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 29, 2024) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Semsysco GmbH Austria Lam Research Belgium BV Belgium Novellus Systems, Inc. |
|
| August 29, 2024 |
Exhibit 19.1 Document Name: LGL-70983 Insider Trading [LGL-1001] Policy Revision: 13.0 Page 1 of 16 Authorized By Title: VP Legal, Corporate Legal Services 1.0Statement of Policy Except as expressly permitted by this Insider Trading Policy (inclusive of Appendix A, referred to herein as the “Policy”), Lam Research Corporation prohibits any transaction in its securities by a person possessing mater |
|
| August 29, 2024 |
Executive Severance Policy, as amended and restated. Exhibit 10.26 Executive Severance Policy EXECUTIVE SEVERANCE POLICY Amended and Restated Effective May 15, 2024 This Executive Severance Policy (this “Policy”) is adopted by the Board of Directors (the “Board”) of Lam Research Corporation, a Delaware corporation (the “Company”) and is amended and restated with an effective date of May 15, 2024. It is intended to comply with ERISA and with all othe |
|
| August 29, 2024 |
Policy for the Recovery of Erroneously Awarded Compensation. Exhibit 97.1 LAM RESEARCH CORPORATION Policy for the Recovery of Erroneously Awarded Compensation Effective December 1, 2023 Purpose As required pursuant to the listing standards of the Nasdaq Stock Market LLC (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Board of Directors (the “Board”) of La |
|
| July 31, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 30, 2024 FREMONT, Calif., July 31, 2024 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 30, 2024 (the “June 2024 quarter”). Highlights for the June 2024 quarter were as follows: •Revenue of $3.87 billion. •U. |
|
| July 31, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 A. Full tit |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| May 31, 2024 |
Conflict Minerals Report of Lam Research Corporation. Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2023 through December 31, 2023 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, for |
|
| May 21, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporatio |
|
| May 21, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Announces $10 Billion Share Repurchase Authorization and a 10-for-1 Stock Split FREMONT, Calif. - (PRNewswire) –May 21, 2024 — Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $10 billion share repurchase authorization and a forward split of its outstanding shares of common stock at a ratio of |
|
| April 29, 2024 |
Exhibit 10.3 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to [Print Name] (the “Participant”) on the ter |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEARCH |
|
| April 29, 2024 |
Exhibit 10.4 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to [Print Name] (the “Participant”) o |
|
| April 29, 2024 |
Exhibit 10.2 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”), Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to [Print Name] (the “Participant”) on the terms and conditions as set forth in this Res |
|
| April 29, 2024 |
Exhibit 10.1 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”), Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to [Print Name] (the “Participant) on the terms and conditions as set forth in this Restricted St |
|
| April 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| April 24, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 31, 2024 FREMONT, Calif., April 24, 2024 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 31, 2024 (the “March 2024 quarter”). Highlights for the March 2024 quarter were as follows: •Revenue of $3.79 billion |
|
| February 13, 2024 |
LRCX / Lam Research Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01312-lamresearchcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Lam Research Corp Title of Class of Securities: Common Stock CUSIP Number: 512807108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate |
|
| January 29, 2024 |
Exhibit 10.1 LAM RESEARCH CORPORATION INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of [date] by and between Lam Research Corporation, a Delaware corporation (the “Company”), and [Print Name] (“Indemnitee”). RECITALS WHEREAS, the Company desires to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve the Company; WHEREAS, |
|
| January 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 24, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEA |
|
| January 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 24, 2024 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| January 24, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 24, 2023 FREMONT, Calif., January 24, 2024 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 24, 2023 (the “December 2023 quarter”). Highlights for the December 2023 quarter were as follows: •Revenue of |
|
| November 9, 2023 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF LAM RESEARCH CORPORATION Amended and restated as of November 8, 2023 ARTICLE I CORPORATE OFFICES 1.1REGISTERED OFFICE The registered office of the corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. The name of the registered agent of the corporation at such location is The Corporation Trust Company. 1.2OTHER OFFICES T |
|
| November 9, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 24, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESE |
|
| October 18, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended September 24, 2023 FREMONT, Calif., October 18, 2023 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 24, 2023 (the “September 2023 quarter”). Highlights for the September 2023 quarter were as follows: •Revenu |
|
| October 18, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 18, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| September 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| September 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| August 24, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 23, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| August 24, 2023 |
Lam Research Appoints General Electric Alum John M. Dineen to Board of Directors Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Appoints General Electric Alum John M. Dineen to Board of Directors FREMONT, Calif., August 24, 2023 – Lam Research Corp. (NASDAQ: LRCX) today announced that John M. Dineen has joined its board of directors, effective August 24, 2023. Dineen brings to Lam extensive experience in technology, operations, and international business management, including |
|
| August 15, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 25, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 15, 2023 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 15, 2023) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Semsysco GmbH Austria Lam Research Belgium BV Belgium Novellus Systems, Inc. |
|
| July 26, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 25, 2023 FREMONT, Calif., July 26, 2023 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 25, 2023 (the “June 2023 quarter”). Highlights for the June 2023 quarter were as follows: •Revenue of $3.21 billion. •U. |
|
| July 26, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 26, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 A. Full tit |
|
| May 31, 2023 |
Conflict Minerals Report of Lam Research Corporation. Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2022 through December 31, 2022 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, for |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEARCH |
|
| April 19, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 19, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| April 19, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 26, 2023 FREMONT, Calif., April 19, 2023 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 26, 2023 (the “March 2023 quarter”). Highlights for the March 2023 quarter were as follows: •Revenue of $3.87 billion |
|
| February 21, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 21, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpo |
|
| February 21, 2023 |
Exhibit 99.1 FOR IMMEDIATE DISTRIBUTION Lam Research Announces New Executive Appointments to Extend Innovation Leadership and Position the Company for Long-Term Growth FREMONT, Calif., February 21, 2023 – Lam Research Corp. (NASDAQ: LRCX) today announced a series of changes to its management structure across operations, innovation, product groups and sales, which together are intended to further p |
|
| February 9, 2023 |
Lam Research Appoints Semiconductor Engineering Leader Dr. Ho Kyu Kang to Board of Directors Exhibit 99.1 Lam Research Appoints Semiconductor Engineering Leader Dr. Ho Kyu Kang to Board of Directors FREMONT, Calif., February 9, 2023 – Lam Research Corporation (NASDAQ: LRCX) today announced that Dr. Ho Kyu Kang has joined its board of directors, effective February 7, 2023. Dr. Kang brings to Lam four decades of experience in leading-edge semiconductor engineering and development. Dr. Kang |
|
| February 9, 2023 |
LRCX / Lam Research Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01272-lamresearchcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Lam Research Corp. Title of Class of Securities: Common Stock CUSIP Number: 512807108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designat |
|
| February 9, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| February 9, 2023 |
Exhibit 10.1 LAM RESEARCH CORPORATION 2004 EXECUTIVE INCENTIVE PLAN Amended and Restated Effective as of February 7, 2023 The Compensation and Human Resource Committee (the “Committee”) of the Board of Directors of Lam Research Corporation (“Company”) hereby adopts this amended and restated version of the 2004 Executive Incentive Plan (“Plan”), effective as of February 7, 2023. 1. Purpose. The pur |
|
| January 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 25, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEA |
|
| January 30, 2023 |
Exhibit 10.2 EXECUTION VERSION AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT THIS AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of December 7, 2022, is entered into by and among LAM RESEARCH CORPORATION, a Delaware corporation (the “Borrower”), the lending institutions party hereto (each a “Lender” and, collectively, the “Lenders”) a |
|
| January 30, 2023 |
Exhibit 10.1 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to the Grantee (the “Participant) on the terms and conditions as set forth in this Restricted Stoc |
|
| January 25, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2023 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| January 25, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 25, 2022 FREMONT, Calif., January 25, 2023 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 25, 2022 (the “December 2022 quarter”). Highlights for the December 2022 quarter were as follows: •Revenue of |
|
| November 10, 2022 |
Submission of Matters to a Vote of Security Holders Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 08, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| October 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 25, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESE |
|
| October 19, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 19, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended September 25, 2022 FREMONT, Calif., October 19, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 25, 2022 (the “September 2022 quarter”). Highlights for the September 2022 quarter were as follows: •Revenu |
|
| September 28, 2022 |
DEFA14A 1 tm2219406d3defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary P |
|
| September 28, 2022 |
TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 19, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 14, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| August 24, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 26, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 24, 2022 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 24, 2022) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Lam Research Belgium BV Belgium Novellus Systems, Inc. |
|
| July 27, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 27, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| July 27, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 26, 2022 FREMONT, Calif., July 27, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 26, 2022 (the ?June 2022 quarter?). Highlights for the June 2022 quarter were as follows: ?Revenue of $4.64 billion. ?U. |
|
| June 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K 11-K 1 lrcx11-kxdocumentx2021.htm 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| May 31, 2022 |
Conflict Minerals Report of Lam Research Corporation. EX-1.01 2 ex101conflictmineralsrepor.htm EX-1.01 Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2021 through December 31, 2021 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgate |
|
| May 11, 2022 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF LAM RESEARCH CORPORATION Amended and restated as of May 11, 2022 ARTICLE I CORPORATE OFFICES 1.1REGISTERED OFFICE The registered office of the corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. The name of the registered agent of the corporation at such location is The Corporation Trust Company. 1.2OTHER OFFICES The b |
|
| May 11, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Announces $5 Billion Share Repurchase Authorization and Declares Quarterly Dividend FREMONT, Calif. - (GLOBE NEWSWIRE) ? May 11, 2022 - Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $5 billion share repurchase authorization and a quarterly dividend of $1.50 per share of common stock. The co |
|
| May 11, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 11, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| May 11, 2022 |
Exhibit 10.1 Lam Research Corporation Senior Executive Transition Policy Purpose To memorialize a policy (the ?Policy?) to provide an opportunity for eligible executives of Lam Research Corporation (the ?Company?) to work a mutually agreed reduced schedule in anticipation of subsequent retirement with the aim of promoting more orderly transitions of senior executives in such circumstances (a ?Tran |
|
| April 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 27, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEARCH |
|
| April 20, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 20, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| April 20, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 27, 2022 FREMONT, Calif., April 20, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 27, 2022 (the ?March 2022 quarter?). Highlights for the March 2022 quarter were as follows: ?Revenue of $4.06 billion |
|
| February 10, 2022 |
LRCX / Lam Research Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Lam Research Corp. Title of Class of Securities: Common Stock CUSIP Number: 512807108 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ? |
|
| February 1, 2022 |
Non-employee Director Compensation Program Ex 10.1 Lam Research Corporation Non-Employee Director Compensation Program Effective November 8, 2021 Objective To target and pay the non-employee members of the board of directors (the ?Board?) of Lam Research Corporation (the ?Company?) at the median of the Company?s peer group, as measured every other year. Annual Cash Retainers For service as a director beginning with calendar year 2022, dire |
|
| February 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 26, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEA |
|
| January 26, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 26, 2021 FREMONT, Calif., January 26, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 26, 2021 (the ?December 2021 quarter?). Highlights for the December 2021 quarter were as follows: ?Revenue of |
|
| January 26, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 26, 2022 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| November 16, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| November 12, 2021 |
Submission of Matters to a Vote of Security Holders Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 08, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| October 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 26, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESE |
|
| October 20, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended September 26, 2021 FREMONT, Calif., October 20, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 26, 2021 (the ?September 2021 quarter?). Highlights for the September 2021 quarter were as follows: ?Revenu |
|
| October 20, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 20, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| September 28, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? ? |
|
| September 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Us |
|
| August 17, 2021 |
Ex 10.35 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards restricted stock units (?RSUs?) to the Grantee (the ?Participant?) on the terms and conditions as set forth in this Restricte |
|
| August 17, 2021 |
Ex 10.31 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards market-based performance restricted stock units (?mPRSUs?) to the Grantee (the ?Participant?) on the terms an |
|
| August 17, 2021 |
Ex 10.37 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards market-based performance restricted stock units (?mPRSUs?) to the Grantee (the ?Participant?) on the |
|
| August 17, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 27, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 17, 2021 |
Ex 10.36 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards market-based performance restricted stock units (?mPRSUs?) to the Grantee (the ?Participant?) on the terms an |
|
| August 17, 2021 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 17, 2021) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Lam Research Belgium BV Belgium Novellus Systems, Inc. |
|
| August 17, 2021 |
Ex 10.33 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Nonstatutory Stock Option Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby grants Options to the Grantee (the ?Optionee?) on the terms and conditions as set forth in this Nonstatutory Stock Option Award |
|
| August 17, 2021 |
Exhibit 10.29 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Nonstatutory Stock Option Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby grants Options to the Grantee (the ?Optionee?) on the terms and conditions as set forth in this Nonstatutory Stock Option Award Agre |
|
| August 17, 2021 |
Ex 10.34 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards restricted stock units (?RSUs?) to the Grantee (the ?Participant) on the terms and conditions as set forth in this Restricted Stock Un |
|
| August 17, 2021 |
Ex 10.32 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Nonstatutory Stock Option Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby grants Options to the Grantee (the ?Optionee?) on the terms and conditions as set forth in this Nonstatutory Stock Option Award Agreement |
|
| August 17, 2021 |
Ex 10.30 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the ?Plan?) Lam Research Corporation, a Delaware corporation (the ?Company?), hereby awards restricted stock units (?RSUs?) to the Grantee (the ?Participant) on the terms and conditions as set forth in this Restricted Stock Un |
|
| July 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 28, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| July 28, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 27, 2021 FREMONT, Calif., July 28, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 27, 2021 (the ?June 2021 quarter?). Highlights for the June 2021 quarter were as follows: ?Revenue of $4.15 billion. ?U. |
|
| June 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K 11-K 1 lrcx11-kxdocumentx2020.htm 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com |
|
| June 21, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 17, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| June 21, 2021 |
Exhibit 10.1 EXECUTION COPY SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 17, 2021 among LAM RESEARCH CORPORATION the Lenders Party Hereto JPMORGAN CHASE BANK, N.A., as Administrative Agent GOLDMAN SACHS BANK USA, BARCLAYS BANK PLC, CITIBANK, N.A., BNP PARIBAS and BANK OF AMERICA, N.A., as Syndication Agents DEUTSCHE BANK SECURITIES INC., MIZUHO BANK, LTD., MUFG BANK, LTD. and TRUI |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| June 1, 2021 |
Conflict Minerals Report of Lam Research Corporation. EX-1.01 2 ex101conflictmineralsrepor.htm EX-1.01 Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2020 through December 31, 2020 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgate |
|
| April 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 28, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEARCH |
|
| April 21, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 28, 2021 FREMONT, Calif., April 21, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 28, 2021 (the ?March 2021 quarter?). Highlights for the March 2021 quarter were as follows: ?Revenue of $3.85 billion |
|
| April 21, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 21, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| March 19, 2021 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| March 19, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| February 12, 2021 |
EX-99.I Exhibit I to Schedule 13G Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows: Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. |
|
| February 12, 2021 |
SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #8 Under the Securities and Exchange Act of 1934 Lam Research Corp (Name of Issuer) Common Stock (Title of Class of Securities) 512807108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 12, 2021 |
to Schedule 13G Joint Filing Agreement EX-99.II Exhibit II to Schedule 13G Joint Filing Agreement The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 12, 2021 in connection with their beneficial ownership of Lam Research Corp. Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and m |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Lam Research Corp. Title of Class of Securities: Common Stock CUSIP Number: 512807108 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 27, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESEA |
|
| January 27, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 27, 2020 FREMONT, Calif., January 27, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 27, 2020 (the “December 2020 quarter”). Highlights for the December 2020 quarter were as follows: •Revenue of |
|
| January 27, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2021 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| January 15, 2021 |
January 15, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N. |
|
| December 28, 2020 |
EX-10.1 Exhibit 10.1 Executive Severance Policy EXECUTIVE SEVERANCE POLICY Effective January 1, 2021 This Executive Severance Policy (this “Policy”) is adopted by the Board of Directors (the “Board”) of Lam Research Corporation, a Delaware corporation (the “Company”) with an effective date of January 1, 2021. It is intended to comply with ERISA and with all other applicable laws. I. DEFINITIONS Th |
|
| December 28, 2020 |
EX-10.2 Exhibit 10.2 Executive Change in Control Policy EXECUTIVE CHANGE IN CONTROL POLICY Effective January 1, 2021 This Executive Change in Control Policy (this “Policy”) is adopted by the Board of Directors (the “Board”) of Lam Research Corporation, a Delaware corporation (the “Company”) with an effective date of January 1, 2021. It is intended to comply with ERISA and with all other applicable |
|
| December 28, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 22, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpo |
|
| December 11, 2020 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| December 11, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 11, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| November 5, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpo |
|
| November 5, 2020 |
FOR IMMEDIATE RELEASE Lam Research Corporation Announces $5 Billion Share Repurchase Authorization and Declares Quarterly Dividend FREMONT, CA - (GLOBE NEWSWIRE) – November 5, 2020 - Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $5 billion share repurchase authorization and a quarterly dividend of $1. |
|
| October 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 LAM RESE |
|
| October 21, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 21, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended September 27, 2020 FREMONT, Calif., October 21, 2020 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 27, 2020 (the “September 2020 quarter”). Highlights for the September 2020 quarter were as follows: •Revenu |
|
| October 15, 2020 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| October 2, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 2, 2020 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| September 23, 2020 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 23, 2020 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| September 14, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 10, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incor |
|
| September 8, 2020 |
Patrick J. Lord Employment Agreement EMPLOYMENT AGREEMENT Effective September 8, 2020 This Employment Agreement (the “Agreement”) is made and entered into effective September 8, 2020 (the “Effective Date”) between Patrick J. Lord (the “Executive”) and Lam Research Corporation, a Delaware corporation (the “Company”). R E C I T A L S A.The Executive and the Company previously entered into a Change i |
|
| September 8, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 8, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| August 18, 2020 |
Subsidiaries of the Registrant. Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 18, 2020) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Lam Research Belgium BVBA Belgium Novellus Systems, Inc. |
|
| August 18, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 28, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 18, 2020 |
Exhibit 4.8 DESCRIPTION OF COMMON STOCK The following summary description sets forth some of the general terms and provisions of the common stock. Because this is a summary description, it does not contain all of the information that may be important to you. For a more detailed description of the common stock, you should refer to the provisions of our Restated Certificate of Incorporation and Amen |
|
| July 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| July 29, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended June 28, 2020 FREMONT, Calif., July 29, 2020 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 28, 2020 (the “June 2020 quarter”). Highlights for the June 2020 quarter were as follows: • Revenue of $2.79 billion. • |
|
| June 19, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 19, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| June 19, 2020 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| June 17, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 A. Full tit |
|
| June 1, 2020 |
- LAM RESEARCH CALENDAR YEAR 2019 FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| June 1, 2020 |
Conflict Minerals Report of Lam Research Corporation. EX-1.01 2 ex101confictmineralsreport.htm EXHIBIT 1.01 CONFLICT MINERALS REPORT Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2019 through December 31, 2019 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rul |
|
| May 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 12, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 18, 2020 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LAM RESEARCH CORPORATION Amended and restated as of May 12, 2020 ARTICLE I CORPORATE OFFICES 1.1 REGISTERED OFFICE The registered office of the corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. The name of the registered agent of the corporation at such location is The Corporation Trust Company. 1.2 OTHER OFFICES The |
|
| May 5, 2020 |
EX-1.1 Exhibit 1.1 LAM RESEARCH CORPORATION $750,000,000 1.900% Senior Notes due 2030 $750,000,000 2.875% Senior Notes due 2050 $500,000,000 3.125% Senior Notes due 2060 Underwriting Agreement April 30, 2020 BofA Securities, Inc. Citigroup Global Markets Inc. Goldman Sachs & Co. LLC J.P. Morgan Securities LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o BofA Secur |
|
| May 5, 2020 |
EX-4.2 Exhibit 4.2 LAM RESEARCH CORPORATION $2,000,000,000 $750,000,000 1.900% SENIOR NOTES DUE 2030 $750,000,000 2.875% SENIOR NOTES DUE 2050 $500,000,000 3.125% SENIOR NOTES DUE 2060 FOURTH SUPPLEMENTAL INDENTURE Dated as of May 5, 2020 To INDENTURE Dated as of February 13, 2015 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. Trustee TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION |
|
| May 5, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation |
|
| May 1, 2020 |
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-229762 CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 1.900% Senior Notes due 2030 $750,000,000 99.670% $747,525,000 $97,029 2.875% Senior Notes due 2050 $75 |
|
| April 30, 2020 |
Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 30, 2020 |
FWP 1 d907884dfwp.htm FWP Filed pursuant to Rule 433 Registration No. 333-229762 Issuer Free Writing Prospectus dated April 30, 2020 Relating to Preliminary Prospectus Supplement dated April 30, 2020 LAM RESEARCH CORPORATION Pricing Term Sheet $750,000,000 1.900% Senior Notes due 2030 $750,000,000 2.875% Senior Notes due 2050 $500,000,000 3.125% Senior Notes due 2060 Issuer: Lam Research Corporati |
|
| April 30, 2020 |
SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 30, 2020 424B5 1 d909801d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-229762 The information in this preliminary prospectus supplement and accompanying base prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offer to sell these securities, and we are not soliciting an offer to buy t |
|
| April 28, 2020 |
Exhibit 10.2 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to the Grantee (the “Participant”) on |
|
| April 28, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0- |
|
| April 28, 2020 |
Exhibit 10.1 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to the Grantee (the “Participant”) on the term |
|
| April 22, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 22, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| April 22, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended March 29, 2020 FREMONT, Calif., April 22, 2020 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 29, 2020 (the “March 2020 quarter”). Highlights for the March 2020 quarter were as follows: • Revenue of $2.50 billio |
|
| March 27, 2020 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| March 27, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| March 17, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 17, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 17, 2020 |
Lam Research Corporation Provides Business Update for the Fiscal Quarter ending March 29, 2020 FOR IMMEDIATE RELEASE Lam Research Corporation Provides Business Update for the Fiscal Quarter ending March 29, 2020 FREMONT, Calif. |
|
| February 14, 2020 |
LRCX / Lam Research Corp. / AMERIPRISE FINANCIAL INC - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #7 Under the Securities and Exchange Act of 1934 Lam Research Corp (Name of Issuer) Common Stock (Title of Class of Securities) 512807108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 14, 2020 |
EX-99.I Exhibit I to Schedule 13G Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows: Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. |
|
| February 14, 2020 |
to Schedule 13G Joint Filing Agreement EX-99.II Exhibit II to Schedule 13G Joint Filing Agreement The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 14, 2020 in connection with their beneficial ownership of Lam Research Corp. Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and m |
|
| February 12, 2020 |
LRCX / Lam Research Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Lam Research Corp Title of Class of Securities: Common Stock CUSIP Number: 512807108 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ R |
|
| February 4, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 29, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number |
|
| January 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 29, 2020 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| January 29, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Reports Financial Results for the Quarter Ended December 29, 2019 FREMONT, Calif., January 29, 2020 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 29, 2019 (the “December 2019 quarter”). Highlights for the December 2019 quarter were as follows: • Revenue o |
|
| December 13, 2019 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| December 13, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) o f the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 13, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorp |
|
| November 7, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 5, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission |
|
| October 29, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 23, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 23, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpor |
|
| October 23, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Contacts: Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected] Lam Research Corporation Reports Financial Results for the Quarter Ended September 29, 2019 FREMONT, Calif., October 23, 2019 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for th |
|
| October 16, 2019 |
LRCX / Lam Research Corp. DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| October 15, 2019 |
LRCX / Lam Research Corp. DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| October 4, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 lrcx8-kconversionratea.htm 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 4, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (Sta |
|
| October 4, 2019 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| September 26, 2019 |
LRCX / Lam Research Corp. S-8 - - S-8 S-8 1 lrcxs-8x401kxsep2019.htm S-8 As filed with the Securities and Exchange Commission on September 26, 2019 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporat |
|
| September 26, 2019 |
Savings Plus Plan, Lam Research 401(k). Volume Submitter Defined Contribution Plan Fidelity Basic Plan Document NO. 17 Fidelity Management & Research Company and its affiliates do not provide tax or legal advice. Nothing herein or in any attachments hereto should be construed, or relied upon, as tax or legal advice. IRS CIRCULAR 230 DISCLOSURE: To the extent this document (including attachments), mentions or references any tax matter, i |
|
| September 25, 2019 |
LRCX / Lam Research Corp. DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| September 25, 2019 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 26, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 21, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorpora |
|
| August 20, 2019 |
Subsidiaries of the Registrant. EX-21 3 exhibit21june2019.htm EXHIBIT 21 Exhibit 21 SUBSIDIARIES OF THE REGISTRANT* SUBSIDIARY (as of August 20, 2019) STATE OR OTHER JURISDICTION OF OPERATION Lam Research AG Austria Lam Research Management GmbH Austria Lam Research Belgium BVBA Belgium Novellus Systems, Inc. California, United States Novellus Systems International, LLC California, United States Lam Research International Holding |
|
| August 20, 2019 |
EX-4.10 2 exhibit410june2019.htm EXHIBIT 4.10 Exhibit 4.10 DESCRIPTION OF COMMON STOCK The following summary description sets forth some of the general terms and provisions of the common stock. Because this is a summary description, it does not contain all of the information that may be important to you. For a more detailed description of the common stock, you should refer to the provisions of our |
|
| August 20, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 0-12933 |
|
| August 14, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporat |
|
| August 14, 2019 |
Exhibit 10.1 AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to Employment Agreement (this “Amendment”) is entered into and effective this 8th day of August, 2019 (the “Effective Date”), by and between Lam Research Corporation, a Delaware corporation (the “Company”), and Timothy M. Archer (the “Executive”). RECITALS WHEREAS, the Executive and the Company (the “Parties”) previously entered into an |
|
| July 31, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporati |
|
| July 31, 2019 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lam Research Corporation Contacts: Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected] Lam Research Corporation Reports Financial Results for the Quarter Ended June 30, 2019 FREMONT, Calif., July 31, 2019 - Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarte |
|
| June 28, 2019 |
LRCX / Lam Research Corp. 11-K - - 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-12933 A. Full tit |
|
| June 14, 2019 |
NOTICE TO HOLDERS OF ANY AND ALL OUTSTANDING 2.625% SENIOR CONVERTIBLE NOTES DUE 2041 OF NOVELLUS SYSTEMS, INC. WITH CUSIP NUMBER 670008 AD3 Pursuant to Section 8.03(l) of the Indenture, dated as of May 10, 2011 (the “Indenture”) between Novellus Systems, Inc., a California corporation, as Issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), as s |
|
| June 14, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 lrcx8-kxconversionrateadj.htm CONVERSION RATE ADJUSTMENT NOTICE 2041 NOTES Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 14, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its |
|
| June 3, 2019 |
FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Frem |
|
| May 31, 2019 |
LRCX / Lam Research Corp. SD - - SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremont, California 94538 (Address of principal exec |
|
| May 31, 2019 |
Conflict Minerals Report of Lam Research Corporation. Exhibit 1.01 LAM RESEARCH CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2018 through December 31, 2018 This Conflict Minerals Report (this “Report”) of Lam Research Corporation (including its consolidated subsidiaries, the “Company”, “Lam”, “we” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, for |
|
| May 13, 2019 |
FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2019 LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-12933 94-2634797 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 4650 Cushing Parkway Fremo |
|
| May 13, 2019 |
Amended and Restated Bylaws of Lam Research Corporation dated May 8, 2019 AMENDED AND RESTATED BYLAWS OF LAM RESEARCH CORPORATION Amended and restated as of May 8, 2019 ARTICLE I CORPORATE OFFICES 1. |
|
| April 30, 2019 |
LRCX / Lam Research Corp. S-8 S-8 ESPP AMENDMENT As filed with the Securities and Exchange Commission on April 30, 2019 Registration No. |
|
| April 30, 2019 |
Lam Research Corporation 1999 Employee Stock Purchase Plan, as amended and restated. Exhibit 4.1 LAM RESEARCH CORPORATION 1999 EMPLOYEE STOCK PURCHASE PLAN Amended and Restated Effective as of August 29, 2018 1. Purpose. This Amended and Restated Lam Research Corporation 1999 Employee Stock Purchase Plan (“Plan”) is amended and restated as of August 29, 2018. The Plan is intended to provide employees of the Company and its Designated Subsidiaries with an opportunity to purchase Co |
|
| April 30, 2019 |
Exhibit 10.3 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement Outside Directors Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to the Grantee (“Participant”) who is an Outside Director of the Company on the terms and conditions |
|
| April 30, 2019 |
Exhibit 10.2 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to the Grantee (the “Participant”) on the terms and conditions as set forth in this Restr |
|
| April 30, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0- |
|
| April 30, 2019 |
EX-10.5 6 lrcx3q2019exhibit10520.htm EXHIBIT 10.5 Exhibit 10.5 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (International Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock unit |
|
| April 30, 2019 |
EX-10.1 2 lrcx3q2019exhibit10120.htm EXHIBIT 10.1 Exhibit 10.1 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards restricted stock units (“RSUs”) to the Grantee (the “Participant) on the terms a |
|
| April 30, 2019 |
Exhibit 10.4 LAM RESEARCH CORPORATION 2015 Stock Incentive Plan Market-Based Performance Restricted Stock Unit Award Agreement (U.S. Participants) Pursuant to the terms of the 2015 Stock Incentive Plan (the “Plan”) Lam Research Corporation, a Delaware corporation (the “Company”), hereby awards market-based performance restricted stock units (“mPRSUs”) to the Grantee (the “Participant”) on the term |
